𝐅𝐫𝐨𝐦 𝐏𝐚𝐩𝐞𝐫 𝐭𝐨 𝐃𝐢𝐠𝐢𝐭𝐚𝐥: 𝐈𝐛𝐞𝐫𝐟𝐚𝐫’𝐬 𝐒𝐡𝐨𝐩 𝐅𝐥𝐨𝐨𝐫 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 At Pharma MES Berlin 2025, IBERFAR, Indústria Farmacêutica S.A. will share their journey of moving from manual, paper-based processes to a fully digital and integrated manufacturing environment. This session will show that digital transformation in pharma is not just an aspiration but an achievable reality, in a highly regulated environment. Key takeaways include:  • How to navigate common challenges in pharmaceutical shop floor digitization projects.  • Defining the right milestones and governance to ensure success.  • Balancing data integrity, operational efficiency, and user adoption.  • Using agile methods and modular Pharma MES implementation to accelerate results. Whether you are just beginning your MES journey or seeking to optimize your current setup, Iberfar’s experience offers practical insights and inspiration to move forward with confidence. Learn more here: https://lnkd.in/epmnMPMU #MESBerlin #MES #DigitalManufacturing #Pharma40 #SmartFactory #LifeSciences #Vimachem #Iberfar

Iberfar and Vimachem @ Pharma MES Berlin 2025 At Pharma MES Berlin 2025, we will share our journey of moving from paper-based processes to a fully digital production environment, a transformation made possible through our partnership with Vimachem. In a highly regulated sector, our experience demonstrates that digitalization is achievable and provides valuable insights for those starting their MES journey or looking to enhance existing systems. 👉 Learn more about our session: https://lnkd.in/epmnMPMU

At Suanfarma Rovereto, innovation and sustainability go hand in hand. Through our collaboration with Alperia Group, we have introduced Sybil, an AI-powered system that optimizes the use of compressed air — a critical resource in pharmaceutical production — making our processes smarter, more stable and more sustainable. This partnership enhances energy efficiency, improves process reliability and reduces our environmental footprint, strengthening our commitment to a greener pharmaceutical industry. 💡 “Sybil is a strategic ally for us, ensuring top-quality processes while reducing consumption and emissions. It perfectly reflects our commitment to a more sustainable pharmaceutical production,” says Nicola Berti, Industrial Operations Director at Suanfarma CDMO. We are proud to join forces with Alperia, bringing cutting-edge AI solutions into the heart of our industry. #Sustainability #AI #EnergyEfficiency #Pharma #Suanfarma #GreenFuture #SuanfarmaCDMO #Alperia 

𝐌𝐞𝐞𝐭 𝐕𝐢𝐦𝐚𝐜𝐡𝐞𝐦 𝐚𝐭 𝐏𝐡𝐚𝐫𝐦𝐚 𝐌𝐄𝐒 𝐁𝐞𝐫𝐥𝐢𝐧: 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐅𝐚𝐬𝐭𝐞𝐬𝐭 𝐏𝐚𝐭𝐡 𝐭𝐨 𝐏𝐡𝐚𝐫𝐦𝐚 𝟒.𝟎 Attending Pharma MES Berlin on September 22–23? So are we, and we’d love to connect. Discover how the Vimachem Pharma MES platform delivers rapid, measurable improvements in manufacturing performance, without the complexity and cost of traditional systems. Want to see how leading manufacturers are:  • Increasing OEE with real-time performance visibility. • Standardizing operations across sites.  • Digitizing compliance, traceability, and shop floor processes. • Improving product quality while reducing manual errors. Let’s talk about how Vimachem can help you accelerate MES adoption and scale smarter operations. #PharmaMES #Pharma40 #MES #PharmaceuticalManufacturing #DigitalTransformation #Vimachem

𝐓𝐡𝐞 𝐍𝐞𝐱𝐭 𝐄𝐫𝐚 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚: 𝐏𝐡𝐚𝐫𝐦𝐚 𝟓.𝟎 ➡ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/dD4zHTU8 Pharma 5.0 Market Size is predicted to grow with a CAGR of 24.6% during the forecast period for 2025-2034. The next phase in the development of the pharmaceutical industry is called Pharma 5.0, and it combines advanced technologies like biotechnology, robots, the Internet of Things, artificial intelligence, and machine learning with a human-centered approach to healthcare. ▪ 𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐇𝐞𝐚𝐥𝐭𝐡 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐚𝐫𝐞: ▪ Johnson & Johnson ▪ Pfizer ▪ Sanofi ▪ Exscientia ▪ XtalPi Inc. ▪ Bristol Myers Squibb ▪ Moderna ▪ GSK ▪ Eli Lilly and Company ▪ Novartis ▪ Roche ▪ AstraZeneca ▪ BioNTech SE ▪ Insilico Medicine ▪ OWKIN #Pharma5 #FutureOfHealthcare #BiotechInnovation #AIinPharma #SmartHealthcare

Cloudbreak, a US-based clinical-stage ophthalmology biotechnology company formed collaborative partnership with its business partner at the Asia Summit on Global Health (ASGH) organised by the Hong Kong Trade Development Council. The company seeks international expansion by leveraging Hong Kong’s financial and trade platforms. #biotech #pharma #medical #healthcare #finance

Angelini Pharma has recently integrated DOMINA into its manufacturing site to meet the growing demand for flexibility, performance and digital integration in tablet production. This presentation at NEXTEN outlines the full journey — from the first trials at IMA to the final validation phases — highlighting how DOMINA was tailored to Angelini’s needs through: • Smart features like automatic sampling, fast turret changeover, and integrated cooling • Custom engineering solutions for powder feeding, statistical reporting, and process control • A comprehensive qualification and validation strategy, ensuring full compliance and seamless integration into Angelini’s production environment The collaboration between Angelini and IMA has proven to be a win-win partnership, combining real-world industrial feedback with cutting-edge innovation in tablet press technology. https://lnkd.in/dMM2exf5 #IMAgroup #IMApharma #NEXTEN

𝐄𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐎𝐫𝐚𝐥 𝐃𝐫𝐮𝐠 𝐑𝐞𝐭𝐞𝐧𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬 ➡ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/dVagkvDH Gastroretentive Drug Delivery Systems Outsourcing Market Size is valued at USD 1.26 Bn in 2022 and is predicted to reach USD 2.32 Bn by the year 2031 at a 7.22% CAGR during the forecast period for 2023-2031. ▪ 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞: ▪ Catalent ▪ Lonza ▪ Evonik ▪ Colorcon® ▪ Quotient Sciences ▪ Nanopharm Ltd, an Aptar Pharma Company ▪ Aenova Group ▪ Evotec ▪ Vectura Group ▪ Ashland ▪ Calera Capital #DrugDelivery #PharmaceuticalInnovation #HealthcareSolutions #GastroretentiveSystems #PatientCare

🌾 𝗪𝗵𝗲𝗮𝘁'𝘀 𝗪𝗲𝗲𝗸𝗹𝘆!! 🌾   #WheatsWeekly - door open in 12-degree "heat" - gotta love the English sunshine!   𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗡𝗲𝘄𝘀   ✅ Enzene Biosciences Ltd announces commercial supply of Pertuzumab. 🥳 Lifecore Biomedical celebrate 60 years of business! ✂️ Catalent opens new global HQ in Tampa, Florida. 𝗠&𝗔 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗲𝗲𝗸   🤝 Bora Biologics and InvaGen Pharmaceuticals Inc partner to manufacture NYPOZI™ at their San Diego facility. 🇹🇭 eXmoor Pharma and Siam Bioscience to launch CGT centre in Bangkok. 📦 Praxis Packaging Solutions acquires ACI (Advanced Concept Innovations, LLC). 𝗘𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗲𝗲𝗸   🏭 Concept Life Sciences officially open their expanded integrated drug discovery facilities at Chapel-en-le-Frith.   🇸🇪 PolyPeptide Group has just announced plans for €100M site expansion for peptides. 🇺🇸 FUJIFILM Biotechnologies officially opens North Carolina site. 🤠 GATTEFOSSÉ opens manufacturing facility in Lufkin, Texas.   𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗲𝗲𝗸   💰AGC Pharma Chemicals invests €110M in Barcelona plant expansion. 🤑 The Ritedose Corporation announced a $17 million investment to expand its in house cGMP laboratory facilities.   𝗡𝗲𝘄 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽   🌟 Pharma Tech Industries name Sam Ricchezza as Senior Managing Advisor, Commercial Operations. 👨🔬 Navin Molecular appoints Dr. Vijay Kaiwar as CEO-CDMO.   Did I miss anything, let me know in the comments! 👇   #CDMO #pharma #biotech

𝗧𝗵𝗶𝘀 𝗪𝗲𝗲𝗸 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 & 𝗠𝗲𝗱𝗧𝗲𝗰𝗵: 𝗠𝗮𝗷𝗼𝗿 𝗠𝗼𝘃𝗲𝘀 𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲! 🚀 This week brought significant developments across the pharmaceutical and medical technology sectors. From billion-dollar acquisitions to regulatory breakthroughs, the industry continues to evolve at breakneck speed. 💰 𝗣𝗳𝗶𝘇𝗲𝗿'𝘀 𝗕𝗼𝗹𝗱 𝗢𝗯𝗲𝘀𝗶𝘁𝘆 𝗣𝗹𝗮𝘆: Pfizer made headlines with its $4.9 billion acquisition of Metsera, marking a strategic re-entry into the competitive obesity drug market. This deal, valued at more than double Metsera's IPO price, signals massive confidence in the weight-loss treatment sector. 💉 𝗙𝗗𝗔 𝗕𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗳𝗼𝗿 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗮𝗿𝗲: The FDA cleared Keytruda QLEX, Merck's new subcutaneous version of its blockbuster cancer immunotherapy. This approval joins similar convenient formulations from Bristol Myers and Roche, making cancer treatment more accessible for patients. 🌍 𝗧𝗿𝗮𝗱𝗲 𝗣𝗼𝗹𝗶𝗰𝘆 𝗧𝗲𝗻𝘀𝗶𝗼𝗻𝘀: Pharma giants Roche and Novartis emphasized their US manufacturing investments as the industry navigates potential 100% tariffs on imported branded drugs. Companies are strategically positioning themselves to avoid trade disruptions. 🏥 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗣𝘂𝘀𝗵: MedTech Europe is pressuring the EU for regulatory changes by early 2026, including postponing re-certification requirements for already certified devices. This reflects ongoing industry concerns about compliance burden. 🔍 𝗨𝗦 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗶𝗼𝗻: The Trump administration launched a Section 232 probe into medical equipment imports, potentially affecting tariffs on essential items like surgical masks, blood glucose monitors, and wheelchairs. 🏆 𝗘𝗦𝗦𝗘𝗥𝗧 𝗥𝗼𝗯𝗼𝘁𝗶𝗰𝘀 𝗪𝗶𝗻𝘀 𝗕𝗶𝗴: And speaking of innovation - we're thrilled to announce that ESSERT Robotics won 2 RAYA Awards (Audience + Best -Innovation) last week! These prestigious awards recognize our cutting-edge contributions to pharmaceutical automation and our MicroFactory Assembly Line showcased with our partner Roche. It's clear that strategic acquisitions, regulatory innovation, and adaptive manufacturing strategies are driving the future of healthcare. The industry continues to balance growth opportunities with evolving policy landscapes. What are your thoughts on these developments? How do you see these trends impacting the future of healthcare innovation? #Pharma #MedTech #LifeSciences #HealthcareInnovation #Robotics